Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 56, Issue 12, Pages 6343-6348
Publisher
American Society for Microbiology
Online
2012-10-09
DOI
10.1128/aac.01291-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Systematic Comparison of Cockcroft-Gault and Modification of Diet in Renal Disease Equations for Classification of Kidney Dysfunction and Dosage Adjustment
- (2012) Eun Jung Park et al. ANNALS OF PHARMACOTHERAPY
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenem antibiotics for serious infections
- (2012) P. M. Hawkey et al. BMJ-British Medical Journal
- TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient
- (2011) Federico Pea et al. ANNALS OF PHARMACOTHERAPY
- Therapeutic drug monitoring of antimicrobials
- (2011) Jason A. Roberts et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
- (2011) G.L. Daikos et al. CLINICAL MICROBIOLOGY AND INFECTION
- The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
- (2011) J.W. Mouton et al. CLINICAL MICROBIOLOGY AND INFECTION
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay
- (2011) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum -lactamase production in clinical Enterobacteriaceae isolates
- (2011) S. Polsfuss et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Implications of augmented renal clearance in critically ill patients
- (2011) Andrew A. Udy et al. Nature Reviews Nephrology
- Use of Meropenem by Continuous Infusion to Treat a Patient with a Blakpc-2-Positive Klebsiella pneumoniae Blood Stream Infection
- (2011) Vanessa P. Ho et al. Surgical Infections
- A Novel Approach to Pharmacodynamic Assessment of Antimicrobial Agents: New Insights to Dosing Regimen Design
- (2011) Vincent H. Tam et al. PLoS Computational Biology
- Comparing Outcomes of Meropenem Administration Strategies Based on Pharmacokinetic and Pharmacodynamic Principles: A Qualitative Systematic Review
- (2010) Jerrold Perrott et al. ANNALS OF PHARMACOTHERAPY
- In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae
- (2010) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
- (2010) Johann D.D. Pitout DRUGS
- Stability of doripenem, imipenem and meropenem at elevated room temperatures
- (2010) Rebecca A. Keel et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Stability of meropenem and doripenem solutions for administration by continuous infusion
- (2010) K. Berthoin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model
- (2010) M. Souli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
- (2009) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Resistance among and Therapeutic Options against Gram‐Negative Pathogens
- (2009) James J. Rahal CLINICAL INFECTIOUS DISEASES
- Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
- (2009) Jason A. Roberts et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Use of Carbapenems in the Treatment of Serious Infections
- (2009) Robert P. Baughman JOURNAL OF INTENSIVE CARE MEDICINE
- Pharmacokinetic and Pharmacodynamic Properties of Meropenem
- (2008) David P. Nicolau CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy
- (2008) Julia Langgartner et al. INTENSIVE CARE MEDICINE
- Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii
- (2008) Donghao Wang INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started